Suzhou
Suzhou
Suzhou, Nanjing, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL | Effects of Chemotherapy; Safety Issues | Enrolling by invitation | Phase 2 | 2024-06-21 | NCT06468943 |